Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Disease With Systemic Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06732674
What this trial is testing

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

Who this might be right for
Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified ElsewhereSystemic Sclerosis PulmonaryDermatomyositis+3 more
Oslo University Hospital 218
Early research (Phase 1)Ended earlyNCT04948554
What this trial is testing

MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)

Who this might be right for
Systemic Sclerosis With and Without Interstitial Lung Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 5
Not applicableNot Yet RecruitingNCT06684132
What this trial is testing

Respiratory Muscle Training in Scleroderma

Who this might be right for
Scleroderma (Limited and Diffuse)
Firat University 30
Not applicableUnknownNCT03858842
What this trial is testing

Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017

Who this might be right for
Lung Diseases, InterstitialLung Disease With Systemic Sclerosis
Hospices Civils de Lyon 100
Testing effectiveness (Phase 2)Looking for participantsNCT06195072
What this trial is testing

Platform Clinical Study for Conquering Scleroderma

Who this might be right for
Interstitial Lung Disease Due to Systemic DiseaseScleroderma
Scleroderma Research Foundation, Inc. 400
Not applicableUnknownNCT05455437
What this trial is testing

Monitoring and Evaluation Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Diseases
Pulmonary Care and Research Collaborative Limited 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06843239
What this trial is testing

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Who this might be right for
Systemic Sclerosis (SSc)Scleroderma
Zura Bio Inc 80
Not applicableStudy completedNCT04484948
What this trial is testing

Utility of Breath-holding Test in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Seoul National University Hospital 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06025578
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Progressive Pulmonary Fibrosis
Bristol-Myers Squibb 1,057
Testing effectiveness (Phase 2)Looking for participantsNCT06189495
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicableLooking for participantsNCT05365009
What this trial is testing

Registry of Autoimmune Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease Due to Systemic Disease
EPIMAR registry 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06947473
What this trial is testing

Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital 45
Post-approval studies (Phase 4)Study completedNCT01042158
What this trial is testing

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

Who this might be right for
Pulmonary Arterial HypertensionSystemic SclerosisScleroderma Spectrum of Diseases+2 more
Johns Hopkins University 25
Testing effectiveness (Phase 2)Looking for participantsNCT07047690
What this trial is testing

Nemolizumab for the Treatment of Adults With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Galderma R&D 162
Not applicableLooking for participantsNCT03269630
What this trial is testing

New Orleans Pulmonary Hypertension Biobank

Who this might be right for
Pulmonary HypertensionSystemic SclerosisMixed Connective Tissue Disease+2 more
Louisiana State University Health Sciences Center in New Orleans 450
Testing effectiveness (Phase 2)Study completedNCT03221257
What this trial is testing

Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate

Who this might be right for
Scleroderma, SystemicInterstitial Lung Disease
Michael Roth 51
Testing effectiveness (Phase 2)Looking for participantsNCT03630211
What this trial is testing

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisDiffuse Sclerosis SystemicInterstitial Lung Disease+1 more
Paul Szabolcs 8
Not applicableUnknownNCT06579651
What this trial is testing

Nailfold Capillaroscopic Pattern Changes and Its Correlation with Interstitial Lung Disease (ILD) in Systemic Sclerosis (SSc) Patients.

Who this might be right for
Systemic Sclerosis (SSc)
Assiut University 45
Testing effectiveness (Phase 2)Ended earlyNCT01559129
What this trial is testing

Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease

Who this might be right for
Scleroderma, SystemicSclerosis, SystemicSystemic Scleroderma+2 more
Celgene 23
Not applicableEnded earlyNCT02243111
What this trial is testing

Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound

Who this might be right for
Systemic SclerosisPulmonary Hypertension
Echosense Ltd. 1
Next Page
30